Euro-Med Laboratories Philippines (PHS:EURO) Scaled Net Operating Assets: 0.77 (As of Mar. 2026)


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
82 GF Score
Price ₱1.08
GF Value ₱1.02
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines Scaled Net Operating Assets?

Euro-Med Laboratories Philippines PHS:EURO -1.82% 82 Scaled Net Operating Assets is 0.77 as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 82/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Euro-Med Laboratories Philippines's operating assets for the quarter that ended in Mar. 2026 was ₱9,404 Mil. Euro-Med Laboratories Philippines's operating liabilities for the quarter that ended in Mar. 2026 was ₱802 Mil. Euro-Med Laboratories Philippines's Total Assets for the quarter that ended in Dec. 2025 was ₱11,145 Mil. Therefore, Euro-Med Laboratories Philippines's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.77.


Euro-Med Laboratories Philippines Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines Scaled Net Operating Assets Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.89 0.87 0.84 0.81

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.83 0.85 0.80 0.77

PHS:EURO vs ZTS, UTHR, VTRS: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euro-Med Laboratories Philippines Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Euro-Med Laboratories Philippines's Scaled Net Operating Assets falls into.


PHS:EURO
82GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Euro-Med Laboratories Philippines's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(9618.156-764.06)/10949.905
=0.81

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11144.61 - 1526.454
=9618.156

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=5076.456 - 962.68 - 3349.716
=764.06

Euro-Med Laboratories Philippines's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(9404.408-801.943)/11144.61
=0.77

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11110.34 - 1705.932
=9404.408

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4957.093 - 920.52 - 3234.63
=801.943

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.77 mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a Scaled Net Operating Assets of 0.77 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' Scaled Net Operating Assets too high?
Euro-Med Laboratories Philippines' current Scaled Net Operating Assets is 0.77. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Scaled Net Operating Assets compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' Scaled Net Operating Assets of 0.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current Scaled Net Operating Assets is 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.08 — trading 5.9% above its estimated fair value. The current Scaled Net Operating Assets is 0.77. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Scaled Net Operating Assets is 0.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.08 is trading 5.9% above its estimated GF Value™ of ₱1.02. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • Scaled Net Operating Assets: 0.77
  • GF Value™: ₱1.02 vs. price of ₱1.08 (5.9% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score

Get the complete analysis for PHS:EURO

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.08
Price
₱1.02
GF Value